Active substances
Mometasone + Salicylic acid
- SFDA 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ELICASAL OINTMENT | 5,0.1 %,% | Ointment · Topical | 1 Tube | SAR 25.55 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| LOCASONE S OINTMENT | 5,0.1 %,% | Ointment · Topical | 1 Tube | SAR 11.50 | Generic · Prescription | DEEF PHARMACEUTICAL INDUSTRIES | Valid |
| LOCASONE S OINTMENT | 5,0.1 %,% | Ointment · Topical | 1 Tube | SAR 38.35 | Generic · Prescription | DEEF PHARMACEUTICAL INDUSTRIES | Valid |
| LOCASONE S OINTMENT | 5,0.1 %,% | Ointment · Topical | 1 Tube | SAR 76.70 | Generic · Prescription | DEEF PHARMACEUTICAL INDUSTRIES | Valid |
| LOCASONE S OINTMENT | 5,0.1 %,% | Ointment · Topical | 1 Tube | SAR 23.00 | Generic · Prescription | DEEF PHARMACEUTICAL INDUSTRIES | Valid |
Indications — CHI Daman Drug Formulary
PSORIASIS
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.